Ultragenyx Pharmaceutical Inc (RARE) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Ultragenyx Pharmaceutical Inc   (NASDAQ: RARE)
 

Ultragenyx Pharmaceutical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2026, Ultragenyx Pharmaceutical Inc has not recorded any inventories.
Visit Ultragenyx Pharmaceutical Inc Balance sheet

Within Healthcare sector 249 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1066 in the first quarter 2026, to 1534.

RARE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ultragenyx Pharmaceutical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RARE Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 26.89 % 19.48 % 15.54 % 20.46 % 15.85 %
Y / Y Cost of Sales Growth - 4.67 % 73.7 % 33.16 % 8.09 %
Inventory Turnover Ratio (TTM) - 2.15 2.22 2.04 1.98
RARE's Total Ranking # 1534 # 1066 # 1136 # 673 # 934
Average inventory processing period - 170 165 179 184
Seq. Inventory Growth 7.27 % 5.77 % -0.38 % 12.26 % 1.01 %
Seq. Cost of Sales Growth - 2.23 % 4.84 % 21.69 % -19.75 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 66
Healthcare Sector # 250
Overall Market # 1534

Inventory Turnover Ratio Statistics
High Average Low
2.22 1.23 0.2
(Dec 31 2025)   (Mar 31 2019)



RARE Company Profile >> Back to RARE Efficiency Comparisons >> Compare RARE Inventory Turnover Ratio to its Competitors

Financial Statements
Ultragenyx Pharmaceutical Inc 's Inventories $ 59 Millions Visit RARE's Balance sheet
Ultragenyx Pharmaceutical Inc 's Cost of Revenues TTM $ 87 Millions Visit RARE's Income Statement
What are RARE's Sales? Visit RARE's Sales by Segment

Other Inventory Turnover Ratios
Ultragenyx Pharmaceutical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RARE's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RARE's Competitors
Inventory Turnover Ratio for RARE's Suppliers
Inventory Turnover Ratio for RARE's Customers

You may also want to know
RARE's Sales Growth Rates RARE's Pe Price to earnings ratio RARE's Receivables Turnover Ratio RARE's Stock Quote
RARE's Net Income Growth Rates RARE's Ps Price to Sales ratio RARE's Sales per Employee RARE's Asset Turnover Ratio
RARE's Net Margin RARE's Pb Price to Book ratio RARE's Financial Strength Ratios RARE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Cadre Holdings inc   3.39 $ 399.991  Millions$ 118  Millions
Bausch Health Companies Inc   3.38 $ 3,783.000  Millions$ 1,120  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions

Date modified: 2026-09-11T09:54:08+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.